Cervical chylous fistula is an uncommon complication after neck dissection, but it might lead to some serious clinical outcomes. Although most cervical chylous fistulas can heal in a few days with standard treatments, some can be intractable. In this study, we describe a new method with local application of Pseudomonas aeruginosa injection for intractable cervical chylous fistula.
Study Design
Case series with chart review.
Setting
West China Hospital, Sichuan University, Chengdu, China.
Subjects and Methods
The charts of 18 patients who were treated with P aeruginosa injection (PAI) for intractable cervical chylous fistula were retrospectively reviewed.
Results
All patients were successfully treated with PAI. Mild fever (temperature, <38°C) occurred in 9 patients, moderate fever (38°C-39°C) in 4 patients, and severe fever (>39°C) in 5 patients. All patients had mild to severe neck pain.
Conclusions
Local application of PAI is an effective method for the treatment of intractable cervical chylous fistula, of which the most common side effects are transient fever and local pain.
American Thyroid Association Guidelines Taskforce on Thyroid Nodule and Differentiated Thyroid Carcinoma, CooperDSDohertyGM. Revised American Thyroid Association management guidelines for patients with thyroid nodules and differentiated thyroid cancer. Thyroid. 2009;19:1167-1214.
2.
TuttleRMBallDWByrdD. Thyroid carcinoma. J Natl Compr Cancer Netw. 2010;8:1228-1274.
3.
CampisiCCBoccardoFPiazzaCCampisiC. Evolution of chylous fistula management after neck dissection. Curr Opin Otolaryngol. 2013;21:150-156.
4.
LucenteFEDiktabanTLawsonWBillerHF. Chyle fistula management. Otolaryngol Head Neck Surg. 1981;89:575-578.
5.
SpiroJDSpiroRHStrongEW. The management of chyle fistula. Laryngoscope. 1990;100:771-774.
6.
KupfermanMEPattersonDMMandelSJLiVolsiVWeberRS. Safety of modified radical neck dissection for differentiated thyroid carcinoma. Laryngoscope. 2004;114:403-406.
7.
RohJLKimDHParkCI. Prospective identification of chyle leakage in patients undergoing lateral neck dissection for metastatic thyroid cancer. Ann Surg Oncol. 2008;15:424-429.
8.
KinnaertP. Anatomical variations of the cervical portion of the thoracic duct in man. J Anat. 1973;115:45-52.
9.
ThawleySE. “How I do it”—head and neck: a targeted problem and its solution: chylous fistula prevention and management. Laryngoscope. 1980;90:522-525.
10.
CrumleyRLSmithJD. Postoperative chylous fistula prevention and management. Laryngoscope. 1976;86:804-813.
11.
MossmanKLMianMFLauzonNM. Cutting edge: FimH adhesin of type 1 fimbriae is a novel TLR4 ligand. J Immunol. 2008;181:6702-6706.
12.
LiZHaoDZhangH. A clinical study on PA-MSHA vaccine used for adjuvant therapy of lymphoma and lung cancer [in Chinese]. Hua Xi Yi Ke Da Xue Xue Bao. 2000;31:334-337.
13.
LiZHaoDLiL. A clinical study on PA-MSHA vaccine in adjuvant therapy of lung cancer [in Chinese]. Zhongguo Fei Ai Za Zhi. 1999;2:20-22.
14.
XuWHLiuZBHouYFHongQHuDLShaoZM. Inhibition of autophagy enhances the cytotoxic effect of PA-MSHA in breast cancer. BMC Cancer. 2014;14:273.
15.
RohJLYoonYHParkCI. Chyle leakage in patients undergoing thyroidectomy plus central neck dissection for differentiated papillary thyroid carcinoma. Ann Surg Oncol. 2008;15:2576-2580.
16.
MingxingLGuowenSZhiyongWWeiH. Novel management of intractable chylous fistula with the application of an impression paste. J Craniofac Surg. 2013;24:e498-e499.
17.
NussenbaumBLiuJHSinardRJ. Systematic management of chyle fistula: the Southwestern experience and review of the literature. Otolaryngol Head Neck Surg. 2000;122:31-38.
18.
CoskunAYildirimM. Somatostatin in medical management of chyle fistula after neck dissection for papillary thyroid carcinoma. Am J Otolaryngol. 2010;31:395-396.
19.
IkedaY. Thoracoscopic management of cervical thoracic duct injuries after thyroidectomy with lymphadenectomy. Asian J Endosc Surg. 2014;7:82-84.
20.
LappGCBrownDHGullanePJMcKneallyM. Thoracoscopic management of chylous fistulae. Am J Otolaryngol. 1998;19:257-262.
21.
GunnlaugssonCBIannettoniMDYuBChepehaDBTeknosTN. Management of chyle fistula utilizing thoracoscopic ligation of the thoracic duct. ORL J Otorhinolaryngol Relat Spec. 2004;66:148-154.
22.
WuGChangXXiaYHuangWKochWM. Prospective randomized trial of high versus low negative pressure suction in management of chyle fistula after neck dissection for metastatic thyroid carcinoma. Head Neck. 2012;34:1711-1715.
23.
BrennanPABlytheJNHerdMKHabibAAnandR. The contemporary management of chyle leak following cervical thoracic duct damage. Br J Oral Max Surg. 2012;50:197-201.
24.
HavasTEGullanePJKasselRN. The incidence and management of chylous fistulae. Aust NZ J Surg. 1987;57:851-854.
25.
MetsonRAlessiDCalcaterraTC. Tetracycline sclerotherapy for chylous fistula following neck dissection. Arch Otolaryngol Head Neck Surg. 1986;112:651-653.
26.
RollonASalazarCMayorgaFMarinRInfanteP. Severe cervical chyle fistula after radical neck dissection. Int J Oral Max Surg. 1996;25:363-365.
27.
Abdel-GalilKMiltonRMcCaulJ. High output chyle leak after neck surgery: the role of video-assisted thoracoscopic surgery. Br J Oral Max Surg. 2009;47:478-480.
28.
van GoorATKrogerRKlompHMde JongMAvan den BrekelMWBalmAJ. Introduction of lymphangiography and percutaneous embolization of the thoracic duct in a stepwise approach to the management of chylous fistulas. Head Neck. 2007;29:1017-1023.
29.
LiuZBHouYFMinD. PA-MSHA inhibits proliferation and induces apoptosis through the up-regulation and activation of caspases in the human breast cancer cell lines. J Cell Biochem. 2009;108:195-206.
30.
CaoZShiLLiY. Pseudomonas aeruginosa: mannose sensitive hemagglutinin inhibits the growth of human hepatocarcinoma cells via mannose-mediated apoptosis. Digest Dis Sci. 2009;54:2118-2127.
31.
OgitaSTsutoTTokiwaKTakahashiT. Intracystic injection of OK-432: a new sclerosing therapy for cystic hygroma in children. Br J Surg. 1987;74:690-691.
32.
Weitz-TuoretmaaARautioRValkilaJKeski-SanttiHKeski-NisulaLLaranneJ. Efficacy of OK-432 sclerotherapy in treatment of lymphatic malformations: long-term follow-up results. Eur Arch Otorhinolaryngol. 2014;271:385-390.
